SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-058209
Filing Date
2022-02-28
Accepted
2022-02-28 17:06:02
Documents
6
Effectiveness Date
2022-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 d267162ds8.htm S-8 30238
2 EX-5.1 d267162dex51.htm EX-5.1 8981
3 EX-23.2 d267162dex232.htm EX-23.2 1502
4 EX-FILING FEES d267162dexfilingfees.htm EX-FILING FEES 18801
5 GRAPHIC g267162dsp7.jpg GRAPHIC 8392
6 GRAPHIC g267162g0225205530210.jpg GRAPHIC 1649
  Complete submission text file 0001193125-22-058209.txt   74615
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263100 | Film No.: 22691153
SIC: 2834 Pharmaceutical Preparations